Results 151 to 160 of about 3,454,417 (246)

Assessment of planning organ at risk volume margins in non-adaptive pancreatic stereotactic body radiotherapy. [PDF]

Phys Imaging Radiat Oncol
Robinson M, Eltinay A, George B, Owens R, Good J, Mukherjee S, Muirhead R.   +6 more
europepmc   +1 more source

Synchronous Vaginal and Liver Metastases in Rectosigmoid Cancer: Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Vaginal metastasis from colorectal cancer is extremely rare. We report the case of a 58‐year‐old postmenopausal woman with rectosigmoid adenocarcinoma and synchronous liver and vaginal metastases who initially presented with gastrointestinal symptoms followed by vaginal bleeding.
Tamader Alyaarabi, Mahmood Al‐Dhaheri, Hamza A. Abdul‐Hafez, Ammar Aleter, Noof Al Naimi, Mohamed Kurer, Mohamed Abunada, Ali Toffaha   +7 more
wiley   +1 more source

Stereotactic body radiotherapy using the CyberKnife system for cutaneous metastasis of hepatocellular carcinoma: a case description. [PDF]

Quant Imaging Med Surg
Wang G, Jia J, Wang Y, Jiao C.
europepmc   +1 more source

Association Between Temporal Muscle Thickness and Survival in Older Patients With Brain Metastases Undergoing Radiation Therapy

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Finding reliable prognostic markers for patients with brain metastases would be beneficial since they could be used in clinical practice when making treatment decisions. Recent literature has analyzed the role of temporalis muscle thickness (TMT) as a prognostic marker in patients with brain metastases with mixed results.
Lasse Pikkarainen, Tommi K. Korhonen, Antti Tolonen, Emilia K. Pesonen, Nicole Hernandez, Tanja Skyttä, Otso Arponen   +6 more
wiley   +1 more source

AI-surrogate structure and dose correlation for left anterior descending artery in lung stereotactic body radiotherapy. [PDF]

J Appl Clin Med Phys
Chang G, Chen Q, Tao R, Zhu L, Rong Y, Yu NY.   +5 more
europepmc   +1 more source

miR‐15a‐5p Regulates Ferroptosis in Glioblastoma by Targeting GLS2

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Schematic diagram of the mechanism by which miR‐15a‐5p regulates glioblastoma progression through targeting GLS2 and modulating ferroptosis. miR‐15a‐5p regulates the ferroptosis pathway by targeting and inhibiting glutaminase 2 (GLS2) expression: Downregulation of miR‐15a‐5p leads to upregulation of GLS2, which promotes lipid peroxidation, accompanied ...
Yanyan Yu, Helan Yuan, Zikun Fang, Jinyuan Liao, Yancong Yang, Jun Liu, Wenjin Wei, Qiuhua Jiang   +7 more
wiley   +1 more source

Can stereotactic body radiotherapy replace brachytherapy in gynecologic cancers? A systematic review of current evidence. [PDF]

Clin Transl Radiat Oncol
Ruiz PV, Vacas AI, Arenas ÁV.
europepmc   +1 more source

Cancer‐related pain: A bidirectional modulator of cancer progression

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
CRP and tumour progression engage in a dynamic, bidirectional circuit mediated by multiple mechanisms involving neuroimmunology and cancer ‐neuroscience. Analgesic interventions may affect tumour progression, while anticancer therapies can influence pain. Targeting pain in cancer may have promising therapeutic value in cancer progression.
Junzhe He, Yu Zhang, Qian Liu, Biao Yan, Peiwei Chai, Renbing Jia   +5 more
wiley   +1 more source

Early Outcomes of Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Retrospective Analysis. [PDF]

Fed Pract
Reddy E, Haque I, Park J, Khaled DT.
europepmc   +1 more source

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)

Frontiers in Oncology, 2021
Rupesh Kotecha, Rupesh Kotecha, Debnarayan Dutta, Rakesh Jalali, Alexander Muacevic   +4 more
doaj   +1 more source